News | Oncology Diagnostics | April 25, 2018

El Camino Hospital Performs First U.S. Robotic Lung Cancer Bronchoscopy

Interventional pulmonology team viewed the inside of the lungs and obtained a tissue sample with the Auris Health Monarch Platform

El Camino Hospital Performs First U.S. Robotic Lung Cancer Bronchoscopy

April 25, 2018 — The interventional pulmonology team at the Taft Center for Clinical Research at El Camino Hospital in Mountain View, Calif., successfully performed an innovative robotic bronchoscopy procedure to view the inside of the lungs and obtain a tissue sample. This procedure, the first of its kind performed in the United States, took place as part of a clinical trial of Auris Health’s Monarch Platform. Auris recently announced U.S. Food and Drug Administration (FDA) clearance of the platform.

According to the American Cancer Society, lung cancer is the second most common cancer in both men and women. It is often the leading cause of cancer deaths in the United States, having a higher mortality than prostate, colon and breast cancers combined, according to the ACS. Approximately 220,000 people are newly diagnosed with lung cancer each year and more than 155,000 people die from the disease annually in the United States.

The early and accurate diagnosis of lung cancer is critical. Today, 90 percent of people who have lung cancer die from the disease, in part because it is often not found until the cancer is at an advanced stage. As the technology to identify lesions improves and screening for lung cancer in at-risk individuals advances, there will be increased requirements for minimally invasive diagnosis.

The Monarch Platform integrates the latest advancements in robotics, software, data science and endoscopy, with the goal of enabling earlier and more-accurate diagnosis, and eventually treatment, of small and hard-to-reach nodules in the periphery of the lung.

“At El Camino Hospital, we utilize a variety of minimally invasive procedures to visualize internal structures, obtain tissue samples and diagnose lung disease. With the use of the Monarch Platform, we are embarking on a paradigm shift in how we diagnose suspicious nodules in the lung. Since the robotic bronchoscope has the ability to travel deeper into the lung and precisely guide a biopsy instrument to even the most difficult nodules, the technology offers the potential to diagnose lung cancer at an earlier stage,” stated Ganesh Krishna, M.D., medical director of the Interventional Pulmonology Program at El Camino Hospital and fellowship director of the Interventional Pulmonary Fellowship Program in collaboration with University of California, San Francisco (UCSF) and Palo Alto Medical Foundation.

For more information: www.aurishealth.com

 

Related Content

SIR President Laura Findeiss, M.D., FSIR

SIR President Laura Findeiss, M.D., FSIR

News | Interventional Radiology | February 09, 2020
February 9, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 07, 2020
February 7, 2020 — An ahead-of-print...
Pulmonary imaging is important in the diagnosis of the acute lung injury associated with vaping, known as electronic cigarette or vaping product use-associated lung injury (EVALI), according to a special review article published in the journal Radiology

Images show electronic cigarette or vaping product use-associated lung injury in a 32-year-old man with history of vaping who presented with fevers and night sweats for 1 week. (a) Coronal maximum intensity projection image shows diffuse centrilobular nodularity. (b) Histologic sections of his transbronchial cryobiopsy showed distinctive micronodular pattern of airway-centered organizing pneumonia, corresponding to centrilobular nodularity seen at CT. Similar imaging and pathologic findings have been described in patients with smoke synthetic cannabinoids. Image courtesy of Radiological Society of North America (RSNA)

News | Lung Cancer | January 28, 2020
January 28, 2020 — Pulmonary imaging is important in the diagnosis of the acute lung injury associated with...
Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population

Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population. Chart courtesy of the American Cancer Society

News | Radiation Oncology | January 13, 2020
January 13, 2020 — The cancer death rate declined
Lung cancer patients who are inactive prior to chemoradiation are less likely to tolerate treatment and more likely to see their cancer return
News | Lung Cancer | January 08, 2020
January 8, 2020 — Numerous ...
The EXALT Model D Single-Use Duodenoscope is intended to provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct disorders and other upper GI problems
News | Endoscopes | December 23, 2019
December 23, 2019 — The U.S. Food and Drug Administration cleared for marketing in the U.S.
 Cancer in lung Siemens PET Biograph mCT Flow Lung
News | Lung Cancer | December 19, 2019
December 19, 2019 — Hoag hopes to turn the tables on
62-year-old woman with pure ground-glass nodules (GGN). PET/CT fusion image shows pure GGN with tumor maximum standardized uptake value of 2.8 (circle).

62-year-old woman with pure ground-glass nodules (GGN). PET/CT fusion image shows pure GGN with tumor maximum standardized uptake value of 2.8 (circle).

News | PET-CT | November 15, 2019
November 15, 2019 — According to an article published ahead-of-print in the...
This chest X-ray of a patient being treated for e-cigarette or vaping-associated lung injury shows lung opacities, densities and whitish cloud-like areas which are typically seen with unusual pneumonias, fluid in lungs or lung inflammation. Image courtesy of Intermountain Healthcare

This chest X-ray of a patient being treated for e-cigarette or vaping-associated lung injury shows lung opacities, densities and whitish cloud-like areas which are typically seen with unusual pneumonias, fluid in lungs or lung inflammation. Image courtesy of Intermountain Healthcare

News | Clinical Trials | November 08, 2019
November 8, 2019 — As the outbreak of lung injuries and deaths associated with e-cigarettes, or...